HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence suggesting the role of norepinephrine deficiency in late stages of Parkinson's disease.

AuthorsH Narabayashi
JournalAdvances in neurology (Adv Neurol) Vol. 80 Pg. 501-4 ( 1999) ISSN: 0091-3952 [Print] United States
PMID10410763 (Publication Type: Journal Article, Review)
Chemical References
  • Antiparkinson Agents
  • Levodopa
  • Dopamine beta-Hydroxylase
  • Droxidopa
  • Norepinephrine
Topics
  • Antiparkinson Agents (therapeutic use)
  • Disease Progression
  • Dopamine beta-Hydroxylase (metabolism)
  • Droxidopa (therapeutic use)
  • Globus Pallidus (surgery)
  • Humans
  • Levodopa (therapeutic use)
  • Norepinephrine (deficiency)
  • Parkinson Disease (enzymology, metabolism, physiopathology, psychology, therapy)
  • Thalamus (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: